This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Zeneca Limited. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Paul Robert Whittamore: Innovator in Pharmaceutical Chemistry
Introduction
Paul Robert Whittamore is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on heterocyclic derivatives. With a total of 3 patents to his name, Whittamore has established himself as a key figure in the industry.
Latest Patents
Whittamore's latest patents include groundbreaking research on quinuclidine derivatives, which serve as squalene synthase inhibitors. These innovations have the potential to impact various therapeutic applications, showcasing his commitment to advancing medical science.
Career Highlights
Whittamore is currently employed at Zeneca Limited, where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company's portfolio but has also enhanced the understanding of complex biochemical processes.
Collaborations
Throughout his career, Whittamore has collaborated with esteemed colleagues such as George R Brown and David R Brittain. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and innovation.
Conclusion
In summary, Paul Robert Whittamore is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His contributions, particularly in the area of heterocyclic derivatives, highlight his role as a leading innovator in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile